| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Automated online tonometry displays a rapid, semi-continuous measurement of gastric-to-endtidal carbon dioxide (Pr-etCO2) as an index of gastrointestinal perfusion during surgery. Its use to predict postoperative outcome has not been studied in general surgery patients. We, therefore, studied ASA physical status IIIIV patients operated on for elective surgery under general anesthesia and a planned duration of >2 h in a European, multicenter study. As each center was equipped with only 1 tonometric monitor, a randomization was performed if more than one patient was eligible the same day. Patients not monitored with tonometry were assessed only for follow-up. The main outcome measure was the assessment of postoperative functional recovery delay (FRD) on day 8. Among the 290 patients studied, 34% had FRD associated with a longer hospital stay. The most common FRDs were gastrointestinal (45%), infection (39%), and respiratory (35%). In those monitored with tonometry (n = 179), maximum Pr-etCO2 proved to be the best predictor increasing the probability of FRD from 34% for all patients to 65% at a cut-off of 21 mm Hg (2.8kPa) (sensitivity 0.27, specificity 0.92, positive predictive value 64%, negative predictive value 70%). We conclude that intraoperative Pr-etCO2 measurement may be a useful prognostic index of postoperative morbidity. IMPLICATIONS: Gastric-to-end tidal partial pressure difference of carbon dioxide (Pr-etCO2) is recognized as an index of gastrointestinal perfusion during surgery. In a high-risk surgical population with an expected duration of surgery of more than 2 h, this European, multicenter observational study suggests that automated semi-continuous monitoring of Pr-etCO2 can be used as an intraoperative predictor of poor outcome.
Multiple organ failure (MOF) is the most common cause of death in surgical intensive care units (ICUs). It is increasingly recognized that milder forms of MOF are associated with a less severe form of organ dysfunction that also increases hospital length of stay and cost. This problem is common; data from two studies revealed an average of 8.5 to 20 additional days in hospital (1,2) that occurred in approximately 15% of patients undergoing major elective surgery (2,3). The etiology of postoperative morbidity is multifactorial, including both severe life-threatening complications such as organ failure but also less severe complications such as wound infection. These overall complications that contribute to prolonged hospitalization and health care cost can be easily and reproducibly identified by the postoperative morbidity survey (POMS) (4). Compromised physiologic reserve (5) and occult hypovolemia (6,7) associated with extensive surgery are thought to represent the most common cause of organ dysfunction and death. In this context, the body reflex defense mechanisms reduce flow to certain end organs (e.g., the gut) to preserve flow to the heart, lung, and brain (6,7). Because the gut is particularly susceptible to hypoperfusion, it has been advocated to provoke distant organ injury by exacerbating the magnitude of systemic inflammation in response to an ischemia/reperfusion injury as well as to release bacteria-derived products (8,9). Consequently, appropriate intervention at an early stage of hypoperfusion might limit the development of MOF and its associated increased morbidity and mortality in high-risk surgical patients. Gastric tonometry is the sole clinically available device allowing monitoring of gastrointestinal perfusion. The initial methodological drawbacks with saline tonometry have been solved by the development of an automated method using air tonometry to measure gastric carbon dioxide (PrCO2) semi-continuously. By referencing PrCO2 to arterial CO2 (Pr-aCO2), this measurement has proved to be an early indicator of shock and a good predictor of postoperative complications in cardiac surgery (10). Its clinical use is limited by the need for arterial sampling, leading to the proposal of gastric-to-end tidal carbon dioxide difference (Pr-etCO2) as a noninvasive marker of regional perfusion. Its usefulness as a reliable method for continuous monitoring of gastric mucosal perfusion has been reported in critically ill (11) and surgical (12) patients. In addition, Lebuffe et al. (13) found that a high Pr-etCO2 on admission to the ICU as well as high Pr-aCO2 were associated with a poorer outcome postcardiac surgery. Hence, semi-continuous monitoring of Pr-etCO2 might allow earlier intraoperative prediction of poor outcome at a time when intervention may be helpful. Therefore, this study was conducted to investigate the relationship between intraoperative increased Pr-etCO2 and the incidence of postoperative complications assessed by POMS.
This prospective, observational study was conducted in 6 major European hospitals. Ethical approval was gained by each participating center before the onset of the study. After written consent was obtained from patients who met the eligibility criteria during a preoperative visit, ASA physical status IIIIV patients scheduled for elective, noncardiac and non-neurological surgery with general anesthesia and a planned duration of more than 2 h were included in the study. The following exclusion criteria were observed: participation in another study, age <18 yr, pregnancy, contraindication to passage of a nasogastric tube, esophageal pathology, and gastric or esophageal surgery. The study was conducted over a period of 6 mo in each center during 1998. Each center was equipped to study only one patient with tonometry at any one time. If more than one patient was eligible in any center on any one day, then one patient was randomly selected to be monitored with automated online tonometry (Tonocap®, Datex-Ohmeda Division, Instrumentarium Corp., Helsinki, Finland). Other patients were assessed for functional recovery delay (FRD) by follow-up only. Randomization was performed by computer (custom software, Datex-Ohmeda Division, Instrumentarium Corp., Helsinki, Finland) before the days surgery starting. If only one patient was eligible for study he or she was monitored with automated online tonometry.
Anesthetic Management
Monitoring
Measurements
where T is end surgical core temperature. End surgical measurements were performed before discharging patients from the operating room. At that time, the following intraoperative data were collected: blood loss >1000 mL, the number of units of blood transfused, the volume of crystalloid and colloid infusion, the end surgical core temperature, and the duration of surgery. The postoperative follow-up was assessed by recording the length of ICU stay and overall postoperative length of stay and hospital outcome. All hospitalized patients were evaluated on postoperative days 2 and 8 using the POMS (4) listed in Table 1. Each assessment was done by speaking with the patient, examining the patient, and consulting the medical record and/or the nurses. FRD was the primary outcome of this study. Given previous work reporting that postoperative length of stay more than 7 days was associated with persistent dysfunction of at least one organ system in noncardiac and non-neurological surgery (4), the presence of at least one criterion of the POMS on postoperative day 8 defined FRD.
All data were recorded in a custom written database (written in Microsoft FoxPro 2.6 for Windows; Microsoft, Redmond, WA). Data entry was checked by random double entry and each center received summary sheets to cross check data entry. Data are expressed as median (range). Differences between categorical variables were tested using the 2 test and the Mann-Whitney U-test was used to test differences between continuous variables according to the presence or absence of FRD. A number of potential predictors of FRD were analyzed. These included Shoemaker risk categories, POSSUM score, maximum Pr-aCO2 difference, maximum Pr-etCO2 difference, end-surgical pHi, and end-surgical base deficit. The primary outcome variable was the ability of Pr-etCO2 to predict FRD. Sensitivity and specificity for the prediction of FRD was calculated for multiple cut-off points according to standard formulae. A routine was written in Microsoft FoxPro to automate the calculations. Data were imported to Microsoft Excel 7.0 for Windows for construction of receiver operating characteristic (ROC) curves. Using the sensitivities and specificities for each cut-off point and the prevalence of FRD among all patients studied, Bayes theorem was used to calculate the probability of FRD in a patient with an abnormal test positive predictive value (PPV) and the probability of FRD in a patient with a normal test (equivalent to 1-negative predictive value [NPV]) (16). The information content (uncertainty before the prediction minus the uncertainty after the prediction) of various ROC cut-off points was assessed according to information theory, taking into account sensitivity, false positive ratio, and the prevalence of FRD in the study patients (17). Information content (I) was calculated for pairs of conditional true positive and false positive probabilities to assess the maximum amount of information available in a series of ROC curves. The test cut-off with the maximum information (Imax) was used as the definition of abnormal for the test. The highest Imax reduces the uncertainty of a decision based on the cut-off to a minimum.
Of 290 patients enrolled in the study over the 6-mo period, 179 patients were monitored with the Tonocap®. For the 290 patients the median age was 69 (2193) years, the proportion of males was 59%, and the median length of stay in ICU and in hospital was 0 (099) and 11 (199) days, respectively (Table 2). On postoperative day 8, 100 patients had FRD (34%) and 15 (5%) died. Because death was not selected as a primary outcome for this study, patients who died were assessed for morbidity on the relevant days if they were alive at that time.
The morbidity experienced by patients on postoperative days 2 and 8 are listed in Table 3. A large proportion of patients remained confined to bed on postoperative day 2. At this time, ambulation was significantly affected by epidural analgesic: of the 88 patients with an epidural, 79 exhibited locomotor problems. On postoperative day 8, all patients confined to bed displayed postoperative complications. Gastrointestinal, respiratory dysfunction, and infection problems were the most common postoperative complications. No direct relationship was found between surgical procedure or use of epidural and the presence of postoperative complications or the incidence of specific types of complications.
When compared with patients with no FRD, those with FRD on postoperative day 8 exhibited a significantly longer length of stay [ICU: 2 (099) versus 0 (07) days; hospital stay: 21 (899) versus 9 (199) days, P < 0.0001]. Similar results were observed in the subgroup of patients monitored with Tonocap® [ICU: 1 (099) versus 0 (099) days; hospital stay: 21 (899) versus 9 (199), P < 0.0001]. For these patients intraoperative characteristics are given in Table 4.
Duration of surgery and amounts in fluid administered were significantly higher in patients with FRD than those without (Table 4). Information theory was used to assess prediction of FRD for the scoring systems, arterial base deficit, and tonometric indices. The abnormal threshold values for predicting FRD (values with the highest Imax) were 2 for Shoemaker risk category, 31 for POSSUM score, 3 mmol/L for end-surgical base deficit, 7.15 for end-surgical pHi, 11 mm Hg (1.5 kPa) for maximum Pr-aCO2, and 21 mm Hg (2.8 kPa) for maximum Pr-etCO2. At these cut-off values, the best predictive power was observed for maximum Pr-etCO2, as Imax value (0.045) was higher than for maximum Pr-aCO2 (0.028), POSSUM score (0.019), end-surgical pHi (0.018), end-surgical base deficit (0.010), or Shoemaker risk category (0.006). At this cut-off value, maximum Pr-etCO2 increased probability of FRD from 35% to 65% (Fig. 1). Predictive value for each test is given in Table 5.
Because the best predictive power was found for maximum Pr-etCO2, further analysis was undertaken to assess the effect of a prolonged Pr-etCO2 gap. On the assumption that there is a cumulative effect of Pr-etCO2 gap, an analysis was required that took into account the duration as well as the level of Pr-etCO2. As gastric-to-end tidal PCO2 difference was being measured every 10 min a cumulative sum of Pr-etCO2 above a "normal" baseline gap was calculated and assessed for predictive power. There are no data on what should be considered as normal; therefore, multiple ROC curves were constructed with incremental levels of assumed normal. The highest Imax gave a reasonable estimate of assumed normal as 8.25 mm Hg (1.1 kPa) (data not shown). The abnormal threshold of cumulative Pr-etCO2 above 8.25 mm Hg (1.1 kPa) was 150 mm Hg (20 kPa). At this cut-off the probability of FRD was increased from 35% to 64% (Table 5).
The use of Pr-etCO2 offers the possibility for online measurement of gastrointestinal CO2 referenced to systemic values without the need for arterial blood sampling. A high Pr-etCO2 is regarded as indicative of an imbalance between gastric perfusion and alveolar ventilation and is not affected by systemic acid-base status. The principal observation of the present study is that maximum Pr-etCO2 measured during the operative course could predict FRD. This is the first study to evaluate the capacity of intraoperative Pr-etCO2 to predict postoperative complications in high-risk surgical patients after major surgery. After cardiac surgery, Bennett-Guerrero et al. (10), using gas tonometry, reported that Pr-aCO2 was a predictor of prolonged hospitalization. Similarly, Lebuffe et al. (13) observed that hospital length of stay was significantly increased (5 days) in postcardiac surgery patients with a Pr-aCO2 between 12 mm Hg (1.6 kPa) and 20 mm Hg (2.7 kPa). Interestingly, in these patients the same trend was observed with Pr-etCO2 values ranging between 18 mm Hg (2.4 kPa) and 28 mm Hg (3.7 kPa). In the present study, the cut-off that maximized the certainty of prediction was 21 mm Hg (2.8 kPa) for maximum Pr-etCO2. Because most previous studies were performed in critically ill patients using pHi, there are currently no data concerning the threshold value of Pr-etCO2 in surgical patients. In the ICU, Pr-aCO2 has recently been shown to predict death for values more than 20 mm Hg (2.6 kPa) (18). However, Pr-etCO2 depends both on Pr-aCO2 and on the difference between arterial and end tidal PCO2 (Pa-etCO2). Previous data in patients without preoperative cardiac dysfunction suggest that a high Pr-etCO2 could be mainly attributed to Pr-aCO2 increase whereas Pa-etCO2 would not exceed 3.8 to 7.6 mm Hg (0.5 to 1.0 kPa) (12,13). This suggests that the cut-off we found for Pr-etCO2 corrected for Pa-etCO2 is near the value of 20 mm Hg (2.6 kPa) for Pr-aCO2 reported in an experimental study as the cut-off point for anaerobic metabolism (19). Gastric tonometry can detect hypovolemia within minutes (20). With its brief period of equilibration, the automated-air gastric tonometry provides Pr-etCO2 values every 10 minutes, allowing calculation of a cumulative sum of Pr-etCO2 above the "normal" baseline gap. There is currently no evidence that brief transient episodes of gastric hypoperfusion are clinically relevant. In contrast, several authors have demonstrated in critically-ill patients that a persistently abnormal pHi (21) or Pr-aCO2 (18) value during the first 24 hours after ICU admission was associated with increased mortality. In our study, the maximum certainty for prediction was observed at a cumulative Pr-etCO2 of 150 mm Hg (20 kPa) above a "normal" level of 8.25 mm Hg (1.1 kPa). There was no gain in predictive power of this calculation compared to assessment of maximum Pr-etCO2 gap. It is interesting to note that 12 measurements of a Pr-etCO2 value just above 21 mm Hg (2.8 kPa) would be required to achieve the cut-off of 150 mm Hg (20 kPa). Because automated gastric tonometry can display up to 6 measurements per hour, a patient considered to be abnormal by the maximum Pr-etCO2 would remain normal by the cumulative Pr-etCO2 for 2 hours. This observation may explain why severe and long-lasting episodes of gastric hypoperfusion, as previously reported by low pHi or high Pr-aCO2 at the end of surgery and postoperatively, were as or more robust predictors of postoperative complications than transient episodes with higher sensitivity and specificity. This issue requires further study in which a therapeutic change aimed at decreasing a high intraoperative cumulative Pr-etCO2 value is assessed against outcome in a selected high-risk surgical population.
Our choice of a primary outcome variable warrants comment. Although mortality is the most widely used measure in assessing patient outcome in the ICU, it is an insensitive measure of outcome for elective surgical patients because death is relatively rare. In the present work, the overall mortality was 5%, a value that is consistent with the mortality observed in cardiovascular surgery (10). More important is the assessment of postoperative morbidity as a measure of surgical outcome. However, there are no accepted methods for assessing postoperative morbidity in patients undergoing surgical procedures. The duration of hospital stay cannot be used as the sole criterion to evaluate postoperative morbidity because it is affected by non-medical factors. We decided to measure FRD on postoperative day 8 based on the observation that a postoperative length of stay more than 7 days was associated with persistent dysfunction of at least one organ system (4). The presence of evidence of delayed recovery on postoperative day 8 was considered as a clinically relevant estimate of outcome in our patients. The clinical relevance of this end-point was further supported by the significant longer median hospital length of stay ( Some limitations of this study should be noted. Inclusion criteria were based on the ASA physical status and the expected duration of surgery. Intraoperative management was not standardized; therefore, some patients may have benefited from more aggressive therapeutic intervention (Hawthorne phenomenon) influencing outcome. The operative categories between centers were not homogeneous and specific operations within categories varied between centers. A preponderance of a particular operation in one center might indicate a particular expertise for that surgery with a different rate of FRD than in other centers. We noted that patients undergoing surgery for peripheral vascular disease were at increased risk of postoperative complications compared with patients operated on for plastic or orthopedic back surgery. Therefore, we cannot exclude the possibility that surgical subgroups altered the prognostic value of Pr-etCO2. Although the expected length of surgery was more than 2 hours, approximately 20% of patients had an operative time ranging between 25 and 120 min. Shorter surgical time in these patients may also have reduced the prognostic value of Pr-etCO2. Finally, as with any study, there were some incomplete data sets (6 patients had some missing data) and some protocol violations, particularly with respect to timings of blood gas analyses (only 36% of blood gases taken within 30 min of the start of the surgery and 47% within 30 min of the end of surgery). The protocol violations with respect to blood gas analysis affect the interpretation of end-surgical pHi, end-surgical base deficit, and Pr-aCO2 as predictors. Despite these limitations, our study demonstrates maximum Pr-etCO2 may be a useful prognostic index of postoperative morbidity in a high-risk surgical population with an expected duration of surgery more than 2 hours. These results need validation in another high-risk surgical population. Randomized clinical trials are needed to assess whether intervention to improve the intraoperative Pr-etCO2 measured by an automated online tonometer can improve end organ perfusion and postoperative outcome in high-risk surgical patients.
Tonometers and Tonocap monitors were provided for this study by Datex-Ohmeda Division, Instrumentarium Corp., Helsinki, Finland.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|